Found Annual vs Monthly Plans: 12-Month GLP-1 Costs Compared

Last reviewed: September 5, 2026 Last updated: September 5, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Found's annual plans require full 12-month prepayment—$1,188 for the insurance track, $2,028 for cash-pay semaglutide—but lower the effective monthly rate by $100 to $120 compared to Found's month-to-month billing. Over 12 months, the insurance annual plan saves $1,200 compared to Found's monthly insurance plan, and the cash-pay semaglutide annual saves $1,440 compared to Found's monthly cash-pay rate. PlexusDx offers no 12-month plan; the longest commitment is six months. At the six-month rate, PlexusDx semaglutide injection costs $1,788 over 12 months ($149/month), $240 less than Found's annual cash-pay semaglutide ($2,028/year, $169/month effective rate, prepaid). For tirzepatide, Found's estimated annual prepaid rate ($2,868/year, $239/month effective) edges out PlexusDx's six-month rate ($2,988/year, $249/month) by $120 over 12 months. The decision hinges on prepayment tolerance, insurance eligibility, and whether you need app-based coaching or prefer standalone medication delivery.

At a glance: Found annual vs monthly vs PlexusDx

All Found figures verified July 20, 2026 and September 4, 2026. Found monthly plans bill every 4 weeks (13 cycles per year); 12-month totals shown here use 12 calendar months for comparison consistency. PlexusDx figures verified July 20, 2026. 12-month totals are our calculation. Found's insurance plans may require copays, typically around $30 per visit.

Breaking down Found's annual vs monthly billing

Found structures its pricing around two tracks—insurance and cash-pay—and offers both month-to-month and annual prepaid billing for each.

Insurance track

The monthly insurance plan costs $199 per month with no upfront commitment. Compounded semaglutide or tirzepatide is included; branded medications (Ozempic, Wegovy, Zepbound, Mounjaro) are billed separately. Over 12 months, this plan totals $2,388 (our calculation). Visits may require a copay, typically around $30.

The annual insurance plan requires $1,188 upfront for 12 months, reducing the effective monthly rate to $99. This structure saves $1,200 over 12 months compared to the monthly insurance plan—an average of $100 per month (our calculation). The same copay considerations apply.

Cash-pay track

The monthly cash-pay plan costs $289 per month for compounded semaglutide or $359 per month for compounded tirzepatide, billed with no upfront payment. Over 12 months, semaglutide totals $3,468 and tirzepatide totals $4,308 (our calculation).

The annual cash-pay plan for semaglutide requires $2,028 upfront (billed every 48 weeks), reducing the effective monthly rate to $169. This saves $1,440 over 12 months compared to Found's monthly cash semaglutide plan—an average of $120 per month (our calculation).

The annual cash-pay plan for tirzepatide was verified at an effective rate of $239 per month, totaling approximately $2,868 over 12 months (our calculation, assuming similar prepaid structure). This saves an estimated $1,440 over 12 months compared to Found's monthly cash tirzepatide plan—an average of $120 per month (our calculation). The exact upfront charge for the tirzepatide annual plan was not separately captured in our most recent dataset; the $239 per month figure was verified at checkout in July 2026.

Billing cadence note

Found's monthly plans bill every four weeks, not calendar months, resulting in 13 billing cycles per year. Using Found's own cadence, the $289 monthly cash semaglutide plan would total $3,757 annually ($289 × 13). For comparison consistency with PlexusDx (which bills on calendar months, 12 cycles per year), we use 12-month calculations throughout this analysis. Readers should confirm the exact billing schedule during enrollment.

PlexusDx pricing: no 12-month option, six-month maximum

PlexusDx offers compounded semaglutide and tirzepatide injection with three commitment tiers: month-to-month, three-month, and six-month. There is no 12-month plan.

Semaglutide injection:

• Month-to-month: $189/month → $2,268 over 12 months (our calculation)
• Three-month: $169/month → $2,028 over 12 months (our calculation)
• Six-month: $149/month → $1,788 over 12 months (our calculation)

Tirzepatide injection:

• Month-to-month: $289/month → $3,468 over 12 months (our calculation)
• Three-month: $269/month → $3,228 over 12 months (our calculation)
• Six-month: $249/month → $2,988 over 12 months (our calculation)

The six-month plan requires payment every six months ($894 for semaglutide, $1,494 for tirzepatide), but the total upfront commitment is half that of Found's annual prepaid plans. All PlexusDx prices include medication, provider visit, and free pharmacist check-in. There is no insurance track and no additional membership fee.

Head-to-head: Found annual prepaid vs PlexusDx six-month rate

Semaglutide

Found's annual cash-pay semaglutide plan costs $2,028 over 12 months ($169/month effective rate, paid upfront). PlexusDx's six-month semaglutide rate costs $1,788 over 12 months ($149/month, billed every six months). PlexusDx is $240 cheaper over 12 months, or about $20 per month on average (our calculation).

However, Found's monthly cash-pay semaglutide plan ($289/month, no prepayment) totals $3,468 over 12 months, making it $1,680 more expensive than PlexusDx's six-month rate over the same period (our calculation).

Tirzepatide

Found's estimated annual cash-pay tirzepatide plan costs approximately $2,868 over 12 months ($239/month effective rate, prepaid). PlexusDx's six-month tirzepatide rate costs $2,988 over 12 months ($249/month, billed every six months). Found is $120 cheaper over 12 months, or about $10 per month on average (our calculation).

Found's monthly cash-pay tirzepatide plan ($359/month, no prepayment) totals $4,308 over 12 months, making it $1,320 more expensive than PlexusDx's six-month rate over the same period (our calculation).

What the savings buy you

Found's inclusions

All Found plans—monthly and annual, insurance and cash-pay—include access to the Found app with 24/7 care team messaging, progress tracking, and behavioral coaching. The program is designed as a comprehensive weight-management platform, not just medication delivery. Compounded semaglutide and tirzepatide are included in the base price; branded GLP-1s (Ozempic, Wegovy, Zepbound, Mounjaro) and the newly available Foundayo (orforglipron) are billed separately. Found accepts HSA and FSA payments. The platform states it offers a full refund if you are not clinically eligible after enrollment (verified July 20, 2026).

PlexusDx inclusions

PlexusDx bundles medication, a provider visit, and a free pharmacist check-in into one monthly charge. There is no app, no care team, and no behavioral coaching component. The service is medication-focused: a licensed provider reviews your intake, writes a prescription if appropriate, and a 503A compounding pharmacy ships the medication to your door. An optional genetic testing add-on ($298 standalone, $99 for program members) is available but not required. PlexusDx does not accept insurance.

Decision factors

Upfront payment tolerance

Found's annual plans require $1,188 to $2,868 upfront, depending on track and medication. If you are comfortable committing 12 months of payment in advance and confident in your tolerance and response, the annual rate materially lowers the monthly cost. If you prefer to test medication response before committing, Found's month-to-month plans or PlexusDx's shorter commitment periods reduce financial risk.

Insurance vs cash-pay

If your insurance covers compounded GLP-1 medication or if Found's insurance track accepts your plan, the $99 per month effective annual rate (or $199 monthly) can be the lowest total cost, especially accounting for potential copay assistance. PlexusDx operates cash-pay only and cannot bill insurance. Confirm your insurance eligibility and copay structure with Found before comparing total cost.

Coaching vs medication-only

Found positions itself as a comprehensive program with app-based tracking, 24/7 messaging, and behavioral support. If you value structured accountability and digital coaching, Found's annual plans spread that cost across 12 months at a lower effective rate. If you prefer standalone medication without additional platform features, PlexusDx delivers medication and clinical oversight without the coaching layer.

Billing predictability

Found's monthly plans bill every four weeks (13 cycles per year), which can complicate budgeting. The annual prepaid structure converts this to a single upfront charge with no additional billing for 12 months. PlexusDx bills on calendar months (12 cycles per year) and offers predictable monthly or six-month billing without requiring a full-year commitment.

Choose Found's annual plan if…

• You can pay $1,188 to $2,868 upfront and are confident in a 12-month commitment.
• You have insurance that covers compounded GLP-1 medication and Found accepts your plan, making the $99 per month effective rate accessible.
• You want integrated app-based coaching, 24/7 care team access, and progress tracking alongside medication.
• You prefer the certainty of a single annual charge over recurring monthly billing.
• You are considering tirzepatide and Found's estimated $239 per month annual rate ($2,868 over 12 months, prepaid) fits your budget better than alternatives.

Choose Found's monthly plan if…

• You want to test medication response and program fit before committing to a full year.
• Upfront payment of $1,188+ is not feasible, but you value Found's app and coaching features.
• You prefer the flexibility to cancel anytime without forfeiting a large prepaid amount.
• Your insurance covers visits or medication on a per-month basis and you want to maximize copay benefits incrementally.

Choose PlexusDx if…

• You want the lowest 12-month cost for compounded semaglutide injection without requiring a 12-month prepayment—PlexusDx's six-month rate ($1,788 over 12 months) is $240 less than Found's annual prepaid semaglutide ($2,028 over 12 months).
• You prefer medication-focused service without app-based coaching or behavioral programming.
• You want the option to commit for six months instead of 12, reducing upfront financial exposure while still accessing a lower monthly rate.
• You do not have insurance that covers compounded GLP-1 medication, or you prefer transparent cash-pay pricing without copay uncertainty.
• You value calendar-month billing (12 cycles per year) over Found's four-week cycle (13 cycles per year).

Review records

PlexusDx holds a 4.2-star rating on Trustpilot, with 76% of reviews at five stars and 81% at four stars or higher (captured September 4, 2026). Found holds a 4.1-star rating on Trustpilot based on approximately 732 reviews (captured September 4, 2026).

Methodology and freshness

We captured Found's monthly and annual pricing from the provider's website and verified figures at checkout on July 20, 2026 and September 4, 2026. PlexusDx pricing was verified on July 20, 2026. All 12-month cost projections, savings calculations, and per-month averages are our calculation, derived by multiplying monthly rates by 12 or dividing annual prepaid totals by 12. Found's monthly plans bill every four weeks (13 cycles per year); we used 12-month totals for comparison consistency with PlexusDx, which bills on calendar months. We noted the distinction in the billing cadence section. The exact upfront charge for Found's tirzepatide annual plan was verified at an effective rate of $239 per month in July 2026; the most recent September 2026 capture did not separately document the tirzepatide annual upfront figure, so we estimated the 12-month total by multiplying $239 by 12. Readers should confirm all pricing, eligibility, copay requirements, and billing schedules directly with Found and PlexusDx at enrollment.

Frequently Asked Questions

Does Found's annual plan lock me in for 12 months?

Found states you can cancel anytime in the app (verified July 20, 2026). However, the annual plan requires full upfront payment ($1,188 insurance, $2,028+ cash-pay), and refund terms for voluntary cancellation mid-year are not detailed in the verified pricing documentation. Confirm the refund policy for annual plans before committing.

Can I switch from Found's monthly plan to the annual plan mid-program?

Found's website and verified checkout flows document separate enrollment paths for monthly and annual plans. Whether you can convert an active monthly subscription to annual billing mid-program was not captured in our dataset. Contact Found directly to confirm upgrade or conversion options.

Does PlexusDx offer a 12-month prepaid rate like Found?

No. PlexusDx's longest commitment tier is six months. The six-month rate for semaglutide injection is $149 per month ($894 every six months), totaling $1,788 over 12 months if renewed—$240 less than Found's annual prepaid semaglutide rate over the same period.

Are Found's copays included in the $99 or $199 monthly insurance rates?

No. Found's insurance track pricing ($199 monthly, $99 monthly effective on the annual plan) covers the program and compounded medication, but visits may require a separate copay, typically around $30. Confirm your plan's copay structure and whether your insurance covers compounded GLP-1 medication before calculating total cost.

Which provider is cheaper for tirzepatide over 12 months?

Found's estimated annual cash-pay tirzepatide rate is approximately $2,868 over 12 months ($239/month effective, prepaid). PlexusDx's six-month tirzepatide rate is $2,988 over 12 months ($249/month). Found is about $120 cheaper over 12 months for tirzepatide when comparing the annual prepaid plan to PlexusDx's six-month rate.

Sources

• Found pricing (monthly and annual, insurance and cash-pay tracks), verified at checkout July 20, 2026 and captured from provider website September 4, 2026
• PlexusDx pricing (month-to-month, three-month, six-month rates for semaglutide and tirzepatide injection), verified July 20, 2026
• Found Trustpilot profile (4.1 stars, ~732 reviews), captured September 4, 2026
• PlexusDx Trustpilot profile (4.2 stars, 76% five-star, 81% four-star or higher), captured September 4, 2026
• 12-month cost projections and savings calculations: our calculation, derived from verified monthly and annual rates

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.